Scarica l'app Stockscreener
47.60
5.52%
-2.78
Pre-mercato:
47.57
-0.03
-0.06%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HIMS Giù?
Forum
Previsione
Precedente Chiudi:
$50.38
Aprire:
$50.215
Volume 24 ore:
25.99M
Relative Volume:
0.59
Capitalizzazione di mercato:
$10.26B
Reddito:
$1.78B
Utile/perdita netta:
$164.40M
Rapporto P/E:
68.99
EPS:
0.69
Flusso di cassa netto:
$236.51M
1 W Prestazione:
-8.51%
1M Prestazione:
-25.88%
6M Prestazione:
+59.68%
1 anno Prestazione:
+145.11%
Intervallo 1D:
$47.54
$50.34
Intervallo di 1 settimana:
$47.54
$53.24
Portata 52W:
$13.47
$72.98
Hims Hers Health Inc Stock (HIMS) Company Profile
Nome
Hims Hers Health Inc
Settore
Industria
Telefono
415-851-0195
Indirizzo
2269 CHESTNUT ST, SAN FRANCISCO
Confronta HIMS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
47.60 | 11.65B | 1.78B | 164.40M | 236.51M | 0.69 |
|
PG
Procter Gamble Co
|
155.03 | 360.50B | 83.93B | 15.50B | 15.03B | 6.30 |
|
UL
Unilever Plc Adr
|
59.66 | 149.48B | 65.10B | 6.16B | 0 | 2.4569 |
|
CL
Colgate Palmolive Co
|
86.64 | 72.01B | 19.95B | 2.90B | 3.47B | 3.54 |
|
KVUE
Kenvue Inc
|
22.13 | 41.89B | 15.30B | 1.06B | 1.45B | 0.55 |
|
KMB
Kimberly Clark Corp
|
126.71 | 42.29B | 19.75B | 2.47B | 2.39B | 7.34 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-23 | Downgrade | Needham | Buy → Hold |
| 2025-06-04 | Reiterato | Needham | Buy |
| 2025-04-29 | Downgrade | TD Cowen | Buy → Hold |
| 2025-02-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | Downgrade | Citigroup | Neutral → Sell |
| 2025-01-07 | Iniziato | BTIG Research | Buy |
| 2024-12-17 | Iniziato | Morgan Stanley | Overweight |
| 2024-11-14 | Downgrade | BofA Securities | Buy → Underperform |
| 2024-08-22 | Iniziato | Needham | Buy |
| 2024-08-09 | Downgrade | Imperial Capital | Outperform → In-line |
| 2024-05-22 | Downgrade | Citigroup | Buy → Neutral |
| 2024-04-16 | Downgrade | Jefferies | Buy → Hold |
| 2024-04-10 | Iniziato | Canaccord Genuity | Buy |
| 2024-02-28 | Aggiornamento | Imperial Capital | In-line → Outperform |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2023-12-07 | Iniziato | Imperial Capital | In-line |
| 2023-07-28 | Iniziato | TD Cowen | Outperform |
| 2023-04-11 | Iniziato | Robert W. Baird | Neutral |
| 2023-02-09 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-11-08 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-11-08 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | Iniziato | Truist | Hold |
| 2022-07-15 | Iniziato | SVB Leerink | Underperform |
| 2022-04-14 | Iniziato | Guggenheim | Buy |
| 2022-04-01 | Ripresa | Credit Suisse | Outperform |
| 2022-03-10 | Iniziato | Deutsche Bank | Hold |
| 2021-12-02 | Iniziato | Jefferies | Hold |
| 2021-11-11 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | Iniziato | BofA Securities | Neutral |
| 2021-05-20 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | Iniziato | Truist | Hold |
| 2021-03-09 | Iniziato | Credit Suisse | Neutral |
| 2021-03-02 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-02-17 | Iniziato | Citigroup | Neutral |
| 2021-02-12 | Iniziato | Piper Sandler | Neutral |
| 2021-02-08 | Iniziato | Tigress Financial | Buy |
Mostra tutto
Hims Hers Health Inc Borsa (HIMS) Ultime notizie
Hims & Hers Health (NYSE:HIMS) Trading Down 2.7% on Insider Selling - Defense World
Hims & Hers Health (HIMS): Is This Volatile Disruptor a Strong Buy for the Future of Consumer Healthcare? - AInvest
Hims & Hers Health, Inc. (HIMS) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance
Hims & Hers Health, Inc. (HIMS) Investors: August 25, 2025 Filing Deadline in Securities Class ActionContact Kessler Topaz Meltzer & Check, LLP - FinancialContent
History of Hims & Hers Health: Revolutionizing Personal Wellness Through Telehealth (NYSE:HIMS) - FinancialContent
Hims & Hers Health, Inc. Securities Fraud Class Action - GlobeNewswire
Hims & Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Wolf Haldenstein Before August 25, 2025 to Discuss Your Rights - GlobeNewswire Inc.
Levi & Korsinsky Urges Hims & Hers Health, Inc. (HIMS) Shareholders to Act Before Lead Plaintiff Deadline August 25, 2025 - ACCESS Newswire
Hims & Hers Health, Inc. Sued for Securities Law ViolationsInvestors Should Contact The Gross Law Firm Before August 25, 2025 to Discuss Your RightsHIMS - Morningstar
HIMS & HERS HEALTH, INC. (NYSE: HIMS) SHAREHOLDER ALERT - GlobeNewswire
Securities Fraud Class Action Filed Against Hims & Hers Health, Inc. (HIMS)Levi & Korsinsky Reminds Investors of August 25, 2025 - ACCESS Newswire
HIMS ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Notifies Investors of a Class Action Lawsuit Against Hims & Hers Health, Inc. (HIMS) - StreetInsider
HIMS SECURITIES NEWS: Did Hims & Hers Health, Inc. - GlobeNewswire
Shareholders of Hims & Hers Health, Inc. (HIMS): Protect Your Rights Before August 25, 2025Contact Levi & Korsinsky - ACCESS Newswire
Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline for Securities Fraud Class Action Lawsuit Filed Against Hims & Hers Health, Inc. - FinancialContent
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP - GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health - Morningstar
Securities Class Action Lawsuit Filed Against Hims & Hers Health, Inc. (HIMS)Levi & Korsinsky Represents Shareholders - ACCESS Newswire
HIMS Equity Alert: Kessler Topaz Meltzer & Check, LLP Alerts Shareholders of Securities Fraud Class Action Lawsuit Filed against Hims & Hers Health, Inc. (HIMS) - StreetInsider
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit - PR Newswire
Lobbying Update: $310,000 of HIMS & HERS HEALTH INC. lobbying was just disclosed - Nasdaq
How Hims & Hers Health Is Quietly Changing Healthcare (NYSE:HIMS) - Seeking Alpha
HIMS & HERS HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims - Morningstar
Class Action Lawsuit Filed Against Hims & Hers Health, Inc. (HIMS)Recover LossesContact Levi & Korsinsky Before August 25, 2025 - ACCESS Newswire
Hims & Hers health CEO Dudum sells $2.5m in shares - Investing.com Australia
HIMS Shareholder Reminder: Kessler Topaz Meltzer & Check, - GlobeNewswire
All You Need to Know About Hims & Hers Health (HIMS) Rating Upgrade to Strong Buy - Yahoo Finance
HIMS Investors Have the Opportunity to Lead the Hims & Hers Health Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - StreetInsider
HIMS ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against Hims & Hers Health, Inc.August 25, 2025 Deadline - The Globe and Mail
HIMS SECURITIES FRAUD: Hims & Hers Health, Inc. (NYSE:HIMS) - GlobeNewswire
Weight-Loss Drugs Telehealth Platform Hims & Hers Hit With New Lawsuit - Newsweek
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Contact Levi & Korsinsky by August 25, 2025 Deadline to Join Class Action Against Hims & Hers Health, Inc.(HIMS) - PR Newswire
BofA Securities maintains Hims and Hers stock rating at Underperform By Investing.com - Investing.com Canada
Investors who lost money on Hims & Hers Health, Inc.(HIMS) - GlobeNewswire
Kessler Topaz Meltzer & Check, LLP Reminds HIMS Shareholders of Deadline in Securities Fraud Class Action Lawsuit Filed Against Hims & Hers Health, Inc. (HIMS) - The Malaysian Reserve
HIMS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Hims & Hers Health, Inc. (HIMS) Alleged “Deceptive” - GlobeNewswire
Hims & Hers Stock Surges 90.4% in 3 Months: What's Fueling the Rally? - Yahoo Finance
Important Notice to Long-Term Shareholders of Centene - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming DeadlinesHIMS - PR Newswire
The Gross Law Firm Reminds Hims & Hers Health, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 25, 2025HIMS - PR Newswire
Hims & Hers Executives Face Lawsuit Over Knockoff Wegovy Sales - USA Herald
HIMS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Hims & Hers Health, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Class Action Filed Against Hims & Hers Health, Inc. (HIMS) Over Securities ViolationsContact Levi & Korsinsky Today - ACCESS Newswire
HIMS & HERS HEALTH SHAREHOLDER ALERT: CLAIMSFILER REMINDS - GlobeNewswire
Hims & Hers Health, Inc. (HIMS) Alleged "Deceptive" Marketing of Wegovy Triggers Securities Class ActionsHIMS Investors with Losses Encouraged to Contact Hagens Berman - ACCESS Newswire
Hims & Hers Brass Face Suit Over 'Knockoff' Wegovy Sales - Law360
ROSEN, GLOBAL INVESTOR RIGHTS COUNSEL, Encourages Hims & - GlobeNewswire
Hims & Hers (HIMS) Faces Legal Storm Post Novo Nordisk Breakup - TipRanks
Hims Hers Health Inc Azioni (HIMS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):